AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

NCT01029418 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped The phase II portion was not conducted due to funding issue.

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: AZD6244 and sorafenib

Sponsor

National Cancer Centre, Singapore